IGF1 and hyperinsulinism: Additionally, changes in the endocrine and metabolic microenvironments of obese patients lead to compensatory hyperinsulinemia and increased levels of bioavailable insulin-like growth factor 1, both of which have been linked to the promotion of carcinogenesis and the inhibition of apoptosis [26].